Fosamax: New Lawsuit on Femur Fracture

According to court documents, on June 29th, 2012 a South Carolina woman, Selma Wilson, filed a lawsuit in New Jersey District Court (case no. 3:2012cv04014) alleging she suffered femur fracture from her use of Fosamax. Fosamax, manufactured by Merck, belongs to the class of drugs known as bisphosphonates. It was approved by the FDA in 1995 and developed to treat post-menopausal osteoporosis and Paget's disease of bone. A study published online in May 2012, by the Archives of Internal Medicine, a publication of the American Medical Association, revealed that atypical femoral fractures were associated with bisphosphonate (including Fosamax) use. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Fosamax severe adverse events. [http://www.attorneyone.com/fosamax/

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Fosamax: severe adverse events threat

Fosamax: severe adverse events threat

atypical femoral fractures were associated with bisphosphonate (including Fosamax) use

San Diego, CA (PRWEB) August 20, 2012

The media spotlight is often a double-edged sword. No one knows this better than Selma Wilson and people who filed Fosamax Class Action lawsuit. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

According to court documents, on June 29th, 2012 a South Carolina woman, Selma Wilson, filed a lawsuit in New Jersey District Court (case no. 3:2012cv04014) alleging she suffered femur fracture from her use of Fosamax. Fosamax, manufactured by Merck, belongs to the class of drugs known as bisphosphonates. It was approved by the FDA in 1995 and developed to treat post-menopausal osteoporosis and Paget's disease of bone. The Plaintiff claims she started taking Fosamax in 2005 and in 2010 she suffered a right femur fracture.

A study published online in May 2012, by the Archives of Internal Medicine, a publication of the American Medical Association, revealed that atypical femoral fractures were associated with bisphosphonate (including Fosamax) use.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of severe adverse events from Fosamax, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat from Fosamax remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

According to the FDA analysis [published in May 2012, in the New England Journal of Medicine, bone-strengthening drugs such as Fosamax may have little long-term benefit.

AttorneyOne.com has further information on Fosamax lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/8/prweb9768354.htm.